TA-35 closes 0.53% lower at a three-month low

The TA-35 ended Monday's session in Tel Aviv 0.53% lower, marking a new three-month low. The decline came as weakness in biomed, oil and gas, and insurance stocks pulled on Israel's blue-chip benchmark, according to Investing.com. The report described the move as a closing result for November 2, rather than an intraday indication.

Technology shares lead the decline

Tower Semiconductor was the weakest performer among TA-35 constituents, falling 8.76% after publishing its third-quarter results. Palo Alto Networks declined 4.93%, while Next Vision Stabilized Systems lost 3.35%. The broader pressure was also visible in sector performance: the insurance, technology, and oil and gas groups were among the weaker areas of the session.

Globes reported that Tower and Palo Alto led losses in the first trading session of November, while Teva and Ormat Technologies were among the notable gainers. Globes also reported that the TA-35 fell 0.53% and that the TA-125 gained 0.04%, indicating that the decline was concentrated more heavily in the large-cap benchmark than in the broader market.

Gainers provide limited support

Dimri was the strongest TA-35 constituent, rising 3.34%. Ormat Technologies added 3.20%, and Strauss Group gained 2.31%. Nevertheless, falling shares outnumbered rising shares on the exchange by 283 to 183, with 92 unchanged, according to Investing.com. That breadth points to a broadly weaker session despite gains in selected index names.

For investors, the session combined company-specific pressure around Tower's results with sector weakness across several economically sensitive and market-heavy groups. The TA-35's move therefore reflected both individual earnings reactions and broader selling pressure, while the new three-month low marked a deterioration in short-term market tone. Further index coverage is available on the TA-35 topic page.